Cadila Healthcare, Bayer to extend JV Bayer Zydus Pharma by 3 years
Mumbai: Bayer (South East Asia) Pte Ltd and Cadila Healthcare Limited have announced the extension of their Joint Venture by three years from June 2021.
The companies first entered into an agreement on January 28, 2011 to set up the Joint Venture - Bayer Zydus Pharma Private Limited for the sales and marketing of pharmaceutical products in India, with headquarters in Mumbai.
"Over the last ten years, Bayer Zydus Pharma has been a successful partnership combining Bayer's scientific expertise and commercialization of novel products backed by Cadila Healthcare's strong India presence. The Joint venture company focused on addressing the unmet healthcare needs of patients in India by providing best-in-class innovative health solutions," the release stated.
During the term of the joint venture, the company also launched some of Bayer's global innovative assets like Xarelto, EyleaTM and Visanne in India.
As per a recent statement, "Bayer Zydus Pharma will continue to operate in core therapies including cardiovascular diseases, diabetes, women's health ,ophthalmology and oncology, with new products in the pipeline."
Key products in the company's pharmaceutical portfolio include Xarelto, Glucobay, EyleaTM, Yaz, Mirena and Visanne amongst others.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.